While the company is no longer enjoying the benefit of enormous sales for its COVID treatment Veklury, Gilead is still doing very nicely, thank you very much.
Tag Archive for: Covid-19
Last year GSK made a strategic move to focus solely on biopharma, and it is already realizing the benefits of a more targeted business.
J&J is heading into the remainder of 2023 with a new look and a revised outlook.
Pfizer’s mRNA vaccine, Comirnaty, was the company’s highest-selling product once again, but leaders are looking to the Seagen acquisition for future growth.
Takeda’s top five brands all grew substantially in FY 2022, none by less than 30 percent.
The U.S. Food and Drug Administration authorized the updated vaccine last week for emergency use in individuals aged 12 years and older, but batches of the shots needed additional clearance from the FDA before they could be released.
The company supplied its COVID vaccines to the EU during the pandemic, but the contract for its Omicron-adjusted vaccines ended in August last year and was not renewed.
HHS also announced an investment of $600 million in 12 domestic COVID-19 test manufacturers.
Pfizer had said in August it will launch a cost-cutting program if its COVID-19 vaccine and antiviral treatment keep underperforming expectations in the coming months due to plunging demand.
The approval for the shot from the Medicines and Healthcare products Regulatory Agency follows the European regulatory panel’s recommendation on Thursday.
